PolyPeptide Group AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	368.85	336.79	320.37	280.98	282.13	223.03
Other Revenue	-	-	-	-	-	1.26
Revenue	368.85	336.79	320.37	280.98	282.13	224.3
Revenue Growth (YoY)	13.99%	5.13%	14.02%	-0.41%	25.78%	10.26%
Cost of Revenue	327.33	299.31	315.6	228.99	182.43	151.11
Gross Profit	41.52	37.49	4.77	51.99	99.7	73.19
Selling, General & Admin	48.69	44.25	41.54	40.63	32.5	28.01
Research & Development	1.55	1.1	1.47	1.24	1.41	1.31
Other Operating Expenses	-1.62	-1.9	-4.4	-2.41	-1.61	-0.45
Operating Expenses	48.62	43.44	38.6	39.46	32.3	28.88
Operating Income	-7.11	-5.95	-33.83	12.53	67.4	44.31
Interest Expense	-30.85	-13.85	-5.62	-2.09	-2.82	-3.32
Interest & Investment Income	-	0.59	0.05	0.01	0.01	0.11
Currency Exchange Gain (Loss)	6.18	6.18	-14.5	-1.63	-1.87	-3.16
Other Non Operating Income (Expenses)	-3.63	-3.63	-1.63	-1.25	-0.17	0.07
EBT Excluding Unusual Items	-35.4	-16.66	-55.52	7.57	62.55	38.01
Asset Writedown	-1.49	-1.49	-2.72	-	-	-
Other Unusual Items	-	-	-	-	-2.71	-0.33
Pretax Income	-36.89	-18.15	-58.24	7.57	59.85	37.69
Income Tax Expense	-2.17	1.42	-6.8	-0.2	12.59	6.35
Net Income	-34.72	-19.56	-51.44	7.77	47.26	31.34
Net Income to Common	-34.72	-19.56	-51.44	7.77	47.26	31.34
Net Income Growth	-	-	-	-83.56%	50.81%	21.75%
Shares Outstanding (Basic)	33	33	33	33	32	30
Shares Outstanding (Diluted)	33	33	33	33	32	30
Shares Change (YoY)	1.74%	0.10%	-0.11%	2.74%	7.08%	-
EPS (Basic)	-1.04	-0.59	-1.56	0.24	1.47	1.04
EPS (Diluted)	-1.04	-0.59	-1.56	0.24	1.47	1.04
EPS Growth	-	-	-	-83.98%	41.35%	-
Free Cash Flow	32.53	3.65	-16.41	-69.64	-16.61	8.86
Free Cash Flow Per Share	0.98	0.11	-0.50	-2.11	-0.52	0.29
Dividend Per Share	-	-	-	-	0.289	-
Gross Margin	11.26%	11.13%	1.49%	18.50%	35.34%	32.63%
Operating Margin	-1.93%	-1.77%	-10.56%	4.46%	23.89%	19.76%
Profit Margin	-9.41%	-5.81%	-16.06%	2.76%	16.75%	13.97%
Free Cash Flow Margin	8.82%	1.08%	-5.12%	-24.79%	-5.89%	3.95%
EBITDA	19.84	18.28	-12.31	33.05	83.46	58.44
EBITDA Margin	5.38%	5.43%	-3.84%	11.76%	29.58%	26.05%
D&A For EBITDA	26.95	24.23	21.52	20.53	16.06	14.13
EBIT	-7.11	-5.95	-33.83	12.53	67.4	44.31
EBIT Margin	-1.93%	-1.77%	-10.56%	4.46%	23.89%	19.76%
Effective Tax Rate	-	-	-	-	21.04%	16.85%
Revenue as Reported	370.54	338.77	324.85	283.46	286.22	224.81

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.